Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 8—August 2013


Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013

CME Logo

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at; (4) view/print certificate.

Release date: July 24, 2013; Expiration date: July 24, 2014

Learning Objectives

Upon completion of this activity, participants will be able to:

• Describe the epidemiology and most common settings of infection of norovirus outbreaks in general

• Analyze the epidemiology and clinical presentation of the GII.4 Sydney norovirus infection.

CME Editor

Carol E. Snarey, MA, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Carol E. Snarey, MA, has disclosed no relevant financial relationships.

CME Author

Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.


Disclosures: Eyal Leshem, MD; Mary Wikswo, MPH; Leslie Barclay; Eric Brandt; William Storm, MPH; Ellen Salehi, MPH; Traci DeSalvo, MPH; Tim Davis; Amy Saupe; Ginette Dobbins; Hillary Booth; Christianne Biggs, MS; Katie Garman, MPH; Amy Woron, PhD; Umesh Parashar, MBBS; Jan Vinjé, PhD; and Aron Hall, DVM, have disclosed no relevant financial relationships.


Article Navigation